{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:00:52Z","timestamp":1767135652291,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd006111.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000}}],"reference-count":34,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006111.pub3","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T10:02:38Z","timestamp":1455271358000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Piracetam for reducing the incidence of painful sickle cell disease crises"],"prefix":"10.1002","volume":"2021","author":[{"given":"Amani","family":"Al Hajeri","sequence":"additional","affiliation":[{"name":"Department of Genetics; Ministry of Health; Awali Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbys","family":"Fedorowicz","sequence":"additional","affiliation":[{"name":"Veritas Health Sciences Consultancy Ltd; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD006111.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000084675","article-title":"Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease","volume":"113","author":"Alvim","year":"2005","journal-title":"Acta Haematologica"},{"key":"10.1002\/14651858.CD006111.pub3-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Viana MB Alvim RC Painful crises in children with sickle cell disease are not prevented by piracetam Acta Haematologica 2009 121 1 9 10","DOI":"10.1159\/000205261"},{"issue":"1","key":"10.1002\/14651858.CD006111.pub3-BIB0003|cit3","first-page":"22","article-title":"Piracetam for the treatment of sickle cell disease in children - a double blind test","volume":"19","author":"El-Hazmi","year":"1998","journal-title":"Saudi Medical Journal"},{"key":"10.1002\/14651858.CD006111.pub3-BIB0004|cit4","unstructured":"El-Hazmi MA Warsy AS Al-Fawaz I Farid M Refai S Opawoye AO Piracetam in the treatment of sickle cell disease [abstract] The National Sickle Cell Disease Program Annual Meeting Conference Proceedings; 1995 March 1995 162"},{"issue":"4","key":"10.1002\/14651858.CD006111.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000203788","article-title":"Piracetam is useful in the treatment of children with sickle cell disease","volume":"96","author":"El-Hazmi","year":"1996","journal-title":"Acta Haematologica"},{"issue":"4","key":"10.1002\/14651858.CD006111.pub3-BIB0006|cit6","first-page":"233","article-title":"A preliminary report on piracetam in sickle cell anemia: a double-blind crossover clinical trial and effects on erythrocyte survival","volume":"3","author":"Mikati","year":"1983","journal-title":"The King Faisal Specialist Hospital Medical Journal"},{"issue":"8034","key":"10.1002\/14651858.CD006111.pub3-BIB0007|cit7","first-page":"411","article-title":"Piracetam and acetamide in sickle-cell disease","volume":"2","author":"De Araujo","year":"1977","journal-title":"Lancet"},{"issue":"7995","key":"10.1002\/14651858.CD006111.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(76)91120-X","article-title":"Piracetam in sickle cell anaemia","volume":"2","author":"De Melo","year":"1976","journal-title":"Lancet"},{"issue":"8143","key":"10.1002\/14651858.CD006111.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(80)91261-1","article-title":"Piracetam in sickle cell disease","volume":"1","author":"Franklin","year":"1980","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD006111.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jcp.40.1.99","article-title":"Use of piracetam improves sickle cell deformability in vivo","volume":"40","author":"Gini","year":"1987","journal-title":"Journal of Clinical Pathology"},{"issue":"1","key":"10.1002\/14651858.CD006111.pub3-BIB0011|cit11","first-page":"77","article-title":"Trial prevention of vaso-occlusive crises in homozygote in sickle cell anemia using piracetam","volume":"65","author":"Sonnet","year":"1985","journal-title":"Annales de la Soci\u00e9t\u00e9 belge de m\u00e9decine tropicale"},{"issue":"1","key":"10.1002\/14651858.CD006111.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.26719\/1995.1.1.112","article-title":"Features of sickle-cell disease in Bahrain","volume":"1","author":"Al-Arrayed","year":"1995","journal-title":"Eastern Mediterranean Health Journal"},{"issue":"3","key":"10.1002\/14651858.CD006111.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0005-2795(81)90173-2","article-title":"Effect of piracetam on sickle erythrocytes and sickle hemoglobin","volume":"668","author":"Asakura","year":"1981","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1002\/14651858.CD006111.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3476(05)80897-2","article-title":"Stroke in a cohort study of patients with homozygous sickle cell disease","volume":"120","author":"Balkaran","year":"1992","journal-title":"Journal of Pediatrics"},{"issue":"742","key":"10.1002\/14651858.CD006111.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/pgmj.63.742.605","article-title":"Management of sickle cell disease","volume":"63","author":"Brozovic","year":"1987","journal-title":"Postgraduate Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD006111.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V84.2.643.643","article-title":"The acute chest syndrome in sickle cell disease: incidence and risk factors","volume":"84","author":"Castro","year":"1994","journal-title":"Blood"},{"issue":"7109","key":"10.1002\/14651858.CD006111.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/bmj.315.7109.656","article-title":"The management of patients with sickle cell disease","volume":"315","author":"Davies","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD006111.pub3-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003885.pub2","article-title":"Pneumococcal vaccines for sickle cell disease","author":"Davies","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8034","key":"10.1002\/14651858.CD006111.pub3-BIB0019|cit19","first-page":"411","article-title":"Piracetam and acetamide in sickle-cell disease","volume":"2","author":"Araujo","year":"1977","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD006111.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD006111.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/tropej\/36.4.148","article-title":"The features of sickle cell disease in Saudi children","volume":"36","author":"El-Hazmi","year":"1990","journal-title":"Journal of Tropical Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD006111.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000204681","article-title":"Hydroxyurea for the treatment of sickle cell disease","volume":"88","author":"El-Hazmi","year":"1992","journal-title":"Acta Haematologica"},{"key":"10.1002\/14651858.CD006111.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/clinchem\/4.6.484","article-title":"A new method for starch gel electrophoresis with special reference to the determination of hemoglobin A2","volume":"4","author":"Goldberg","year":"1958","journal-title":"Clinical Chemistry"},{"key":"10.1002\/14651858.CD006111.pub3-BIB0024|cit24","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] In: The Cochrane Library. The Cochrane Collaboration. Chichester, UK: John Wiley & Sons, Ltd; 2005, Issue 3. 2005"},{"issue":"2","key":"10.1002\/14651858.CD006111.pub3-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002202","article-title":"Hydroxyurea for sickle cell disease","author":"Jones","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006111.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/adc.73.4.316","article-title":"Factors associated with lowered intelligence in homozygous sickle cell disease","volume":"73","author":"Knight","year":"1995","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1002\/14651858.CD006111.pub3-BIB0027|cit27","first-page":"110","article-title":"Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects","volume":"43","author":"Moriau","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1002\/14651858.CD006111.pub3-BIB0028|cit28","unstructured":"National Institutes of Health National Heart Lung and Blood Institute The Management of Sickle Cell Disease NIH Publication No. 02-2117 2002"},{"key":"10.1002\/14651858.CD006111.pub3-BIB0029|cit29","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD006111.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5144\/0256-4947.1994.237","article-title":"The geography of sickle-cell disease: opportunity for understanding its diversity","volume":"14","author":"Serjeant","year":"1994","journal-title":"Annals of Saudi Medicine"},{"key":"10.1002\/14651858.CD006111.pub3-BIB0031|cit31","volume-title":"Sickle Cell Disease","author":"Serjeant","year":"2001"},{"issue":"10","key":"10.1002\/14651858.CD006111.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/adc.56.10.765","article-title":"Acute splenic sequestration and hypersplenism in the 5 years of life in homozygous sickle cell disease","volume":"56","author":"Topley","year":"1981","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD006111.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00002512-199101010-00004","article-title":"Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders","volume":"1","author":"Vernon","year":"1991","journal-title":"Drugs and Aging"},{"key":"10.1002\/14651858.CD006111.pub3-BIB0034|cit34","unstructured":"World Health Organization Sickle-cell anaemia. Report A59\/9. Provisional agenda item 11.4. 59th World Health Assembly www.who.int\/gb\/ebwha\/pdf_files\/WHA59\/A59_9-en.pdf"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006111.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T01:02:37Z","timestamp":1644195757000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006111.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006111.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}